1. A look at treatment strategies for relapsed multiple myeloma. Issue 8 (3rd August 2018) Authors: Cetani, Giusy; Boccadoro, Mario; Oliva, Stefania Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 8(2018) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective study of R‐DHAP/Ox for early progressing follicular lymphoma. (19th December 2017) Authors: Ghione, Paola; Cavallo, Federica; Visco, Carlo; Chen, Zhengming; Castellino, Alessia; Tisi, Maria C.; Dogliotti, Irene; Nicolosi, Maura; Boccadoro, Mario; Leonard, John P.; Vitolo, Umberto; Martin, Peter Journal: British journal of haematology Issue: Volume 183:Number 5(2018) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients. (9th November 2021) Authors: Morabito, Fortunato; Zamagni, Elena; Conticello, Concetta; Pavone, Vincenzo; Palmieri, Salvatore; Bringhen, Sara; Galli, Monica; Mangiacavalli, Silvia; Derudas, Daniele; Rossi, Elena; Ria, Roberto; Catalano, Lucio; Tacchetti, Paola; Mele, Giuseppe; Donatella Vincelli, Iolanda; Antonia Martino, En... Journal: European journal of haematology Issue: Volume 108:Number 3(2022) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs. (June 2015) Authors: Festuccia, Moreno; Martino, Massimo; Ferrando, Federica; Messina, Giuseppe; Moscato, Tiziana; Fedele, Roberta; Boccadoro, Mario; Giaccone, Luisa; Bruno, Benedetto Journal: Expert opinion on biological therapy Issue: Volume 15:Number 6(2015:Jun.) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma1. Issue 5 (23rd October 2012) Authors: Petrucci, Maria Teresa; Levi, Anna; Bringhen, Sara; Scotti, Simona; Gentilini, Fabiana; Russo, Simone; Siniscalchi, Agostina; Larocca, Alessandra; Grammatico, Sara; Boccadoro, Mario; Foà, Robin; Palumbo, Antonio Journal: Cancer Issue: Volume 119:Issue 5(2013) Page Start: 971 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study. Issue 11 (2nd November 2017) Authors: Grammatico, Sara; Bringhen, Sara; Vozella, Federico; Siniscalchi, Agostina; Boccadoro, Mario; Petrucci, Maria Teresa Journal: Leukemia & lymphoma Issue: Volume 58:Issue 11(2017) Page Start: 2738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case‐matched study. Issue 4 (5th February 2014) Authors: Morabito, Fortunato; Bringhen, Sara; Larocca, Alessandra; Wijermans, Pierre; Victoria Mateos, Maria; Gimsing, Peter; Mazzone, Carla; Gottardi, Daniela; Omedè, Paola; Zweegman, Sonja; José Lahuerta, Juan; Zambello, Renato; Musto, Pellegrino; Magarotto, Valeria; Schaafsma, Martijn; Oriol, Albert; J... Journal: American journal of hematology Issue: Volume 89:Issue 4(2014:Apr.) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study. Issue 12 (December 2020) Authors: Tacchetti, Paola; Pantani, Lucia; Patriarca, Francesca; Petrucci, Maria Teresa; Zamagni, Elena; Dozza, Luca; Galli, Monica; Di Raimondo, Francesco; Crippa, Claudia; Boccadoro, Mario; Barbato, Simona; Tosi, Patrizia; Narni, Franco; Montefusco, Vittorio; Testoni, Nicoletta; Spadano, Antonio; Terrag... Journal: Lancet Issue: Volume 7:Issue 12(2020) Page Start: e861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗